Chirality is a widely existing property in pharmaceuticals. In general, the chiral enantiomers show higher activity and lower adverse reaction than their racemates. Therefore, the manufacturing of pure chiral enantiomer is of great scientific significance. Crystallization resolution method is an important technique in pharmaceutical industry to achieve the separation of enantiomers. As a novel crystallization technique, cocrystal has attracted much attention due to its broad applicability. In this paper, the history and development of chiral resolution based on cocrystallization are briefly introduced. Meanwhile, the recent progress in this field is classified and summarized according to the structural characteristics of cocrystals formed by racemic drugs. In addition, the main challenges of chiral resolution based on cocrystallization are summarized and prospected.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |